AEYE is up +392.76% since Feb ’24 pick Unlock All Top Buy Picks
Currently predicting for Fri, 24 May 2024

Trading levels for TXMD

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.18 3.48 %
R2 2.15 2.03 %
R1 2.13 1.13 %
Current price: 2.11
Support S1 2.07 -1.76 %
S2 2.05 -2.66 %
S3 2.02 -4.11 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 2.54 20.38 %
R2 2.29 8.53 %
R1 2.15 1.90 %
Current price 2.11
Support S1 1.90 -9.95%
S2 1.89 -10.43%
S3 1.88 -10.90%

TXMD Predictions History

3 years ago
JS predicted that TXMD for 2021-04-09 is going $1.34 (1.52%)

3 years ago
mathieu.nisen+stockinvest1 predicted that TXMD for 2021-04-09 is going $1.52 (15.15%)

Rank:

3 years ago
Crash Cutta predicted that TXMD for 2021-04-01 is going $1.35 (-2.88%)

Rank:

3 years ago
Crash Cutta predicted that TXMD for 2021-03-22 is going $1.60 (5.26%)

Rank:

3 years ago
JS predicted that TXMD for 2021-03-16 is going $1.73 (7.45%)

3 years ago
jjsheets330 predicted that TXMD for 2021-03-16 is going $4.00 (148.45%)

3 years ago
MacSteele13 predicted that TXMD for 2021-03-16 is going $1.63 (-1.81%)

Rank:

3 years ago
JS predicted that TXMD for 2021-03-04 is going $1.48 (13.85%)

3 years ago
dabears5966 predicted that TXMD for 2021-03-04 is going

Rank:

3 years ago
JS predicted that TXMD for 2021-03-03 is going $1.46 (0.00%)

Click to get the best stock tips daily for free!

About TherapeuticsMD Inc

TherapeuticsMD TherapeuticsMD, Inc. operates as a women's healthcare company in the United States. The company offers IMVEXXY for the treatment of moderate-to-severe dyspareunia; BIJUVA, a bio-identical hormone therapy combination of 17ß-estradiol and progesterone for the treatment of moderate-to-severe vasomotor symptoms; and ANNOVERA, a ring-shaped contraceptive vaginal system. Its preclinical projects include the development of TX-005HR, a progesterone-alon... TXMD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT